Neurophet
Neurophet appears in 1 markets tracked by Meridian Consensus across 1 industry (Healthcare). Aggregate market exposure is $4.9B, computed as the sum of (share × market size) across every appearance.
Its strongest position is South Korea Digital Cognitive Assessment and Digital Therapeutics Market at 3.0% share in a market growing at 6.4% CAGR. Average share across all tracked markets is 3.0%, indicating a meaningful incumbent presence.
Each market page below carries the full Porter Five Forces, SWOT, regional sub-data, regulatory landscape, and competitor table the operator competes against. Use the related-operator rail at the bottom of the page to triangulate Neurophet against the peers it actually overlaps with in those segments.
Market positions
Avg share 3.0% · sorted by exposure| Market | Market size | Share | Exposure |
|---|---|---|---|
| South Korea Digital Cognitive Assessment and Digital Therapeutics Market | $162.3B | 3.0% |
Explore adjacent markets
Each market page surfaces Porter Five Forces, SWOT, country analysis, patent filings, regulatory signals, and more, verified against SEC filings, FRED macro series, and trade-association benchmarks.
Operators that compete with Neurophet
Peers that show up alongside Neurophet in the markets above. Ordered by how many overlapping markets they share — the top of the list is who the operator competes against most directly.
- 1 sharedNunapsTop overlap · South Korea Digital Cognitive Assessment and Digital Therapeutics
- 1 sharedHeuronTop overlap · South Korea Digital Cognitive Assessment and Digital Therapeutics
- 1 sharedOtsuka KoreaTop overlap · South Korea Digital Cognitive Assessment and Digital Therapeutics
- Click TherapeuticsTop overlap · South Korea Digital Cognitive Assessment and Digital Therapeutics